Go to Advocacy & Compliance Home
The California Pharmacy and Therapeutic (P&T) Committee will host a hybrid meeting on October 16th to review and discuss the newly proposed pharmaceutical fee schedule and other key issues impacting the workers' compensation drug formulary.
Agenda highlights include:
- Updates to the MTUS drug list
- The inclusion of biosimilar drugs
- A revised look-up tool
- Drug list utilization rates.
Meeting materials are available on the P&T Committee webpage, and the DWC encourages public comments on the formulary drug list to be sent to Formulary@dir.ca.gov.
